Osaic Holdings’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$777K Sell
101,316
-123,812
-55% -$848K ﹤0.01% 2942
2025
Q4
$446K Sell
225,128
-2,364
-1% -$5.36K ﹤0.01% 3439
2025
Q3
$534K Buy
227,492
+25,733
+13% +$66.3K ﹤0.01% 3377
2025
Q2
$533K Buy
201,759
+49,234
+32% +$132K ﹤0.01% 3075
2025
Q1
$459K Buy
152,525
+54,978
+56% +$167K ﹤0.01% 2953
2024
Q4
$250K Sell
97,547
-5,645
-5% -$23.5K ﹤0.01% 3406
2024
Q3
$384K Buy
103,192
+28,338
+38% +$131K ﹤0.01% 3112
2024
Q2
$473K Buy
74,854
+31,697
+73% +$209K ﹤0.01% 2821
2024
Q1
$232K Buy
43,157
+12,609
+41% +$57.1K ﹤0.01% 3564
2023
Q4
$153K Buy
30,548
+1,843
+6% +$5.78K ﹤0.01% 4137
2023
Q3
$48.5K Buy
28,705
+15,827
+123% +$31.8K ﹤0.01% 5027
2023
Q2
$35.8K Sell
12,878
-10,635
-45% -$30.1K ﹤0.01% 5160
2023
Q1
$42.8K Sell
23,513
-2,556
-10% -$7.95K ﹤0.01% 5058
2022
Q4
$133K Sell
26,069
-9,213
-26% -$50.6K ﹤0.01% 4208
2022
Q3
$176K Buy
35,282
+2,763
+8% +$12.6K ﹤0.01% 3872
2022
Q2
$122K Buy
32,519
+20,128
+162% +$80.8K ﹤0.01% 4248
2022
Q1
$69K Buy
12,391
+754
+6% +$4.63K ﹤0.01% 4853
2021
Q4
$71K Sell
11,637
-20,184
-63% -$152K ﹤0.01% 4872
2021
Q3
$309K Buy
31,821
+18,783
+144% +$207K ﹤0.01% 3519
2021
Q2
$186K Buy
13,038
+8,768
+205% +$145K ﹤0.01% 3911
2021
Q1
$102K Buy
4,270
+2,420
+131% +$62.7K ﹤0.01% 4322
2020
Q4
$24K Sell
1,850
-7,650
-81% -$73.6K ﹤0.01% 5044
2020
Q3
$67K Buy
9,500
+8,520
+869% +$84.9K ﹤0.01% 4102
2020
Q2
$12K Buy
980
+382
+64% +$2.16K ﹤0.01% 5090
2020
Q1
$2K Buy
+598
New +$3K ﹤0.01% 5684

Other funds holding IBRX